Ausgewählte Publikationen

Zoellner AK, Fritsch S, Prevalsek D, Engel N, Hubmann M, Reibke R, Rieger CT, Hellmuth JC, Haas M, Mumm F, Herold T, Ledderose G, Hiddemann W, Dreyling M, Hausmann A, Tischer J

Sequential therapy combining clofarabine and T-cell-replete HLA-haploidentical haematopoietic SCT is feasible and shows efficacy in the treatment of refractory or relapsed aggressive lymphoma.

Bone Marrow Transplant. 2015 May;50(5):679-84.


Tischer J, Engel N, Fritsch S, Prevalsek D, Hubmann M, Schulz C, Zoellner AK, Bücklein V, Lippl S, Reibke R, Rieger CT, Ledderose G, Stemmler HJ, Hiddemann W, Schmid C, Hausmann A.

Second haematopoietic SCT using HLA-haploidentical donors in patients with relapse of acute leukaemia after a first allogeneic transplantation.

Bone Marrow Transplant. 2014 Jul;49(7):895-901.


Tischer J, Stemmler HJ, Engel N, Hubmann M, Fritsch S, Prevalsek D, Schulz C, Zoellner AK, Bücklein V, Hill W, Ledderose G, Hausmann A.

Feasibility of clofarabine cytoreduction followed by haploidentical hematopoietic stem cell transplantation in patients with relapsed or refractory advanced acute leukemia.

Ann Hematol. 2013 Oct;92(10):1379-88.


Moosmann A*, Bigalke I*, Tischer J *, Schirrmann L, Kasten J, Tippmer S, Leeping M, Prevalsek D, Jaeger G, Ledderose G, Mautner J, Hammerschmidt W, Schendel DJ, Kolb HJ. *equally contributed.

Effective and long-term control of EBV PTLD after transfer of peptide-selected T cells.

Blood. 2010 Apr 8;115(14):2960-70.


Schmid C, Schleuning M, Ledderose G, Tischer J, Kolb HJ.

Sequential regimen of chemotherapy, reduced-intensity conditioning for allogeneic stem-cell transplantation, and prophylactic donor lymphocyte transfusion in high-risk acute myeloid leukemia

J Clin Oncol. 2005 Aug 20;23(24):5675-87.

Alle in PubMed gelisteten Publikationen dieses Autors

  Verantwortlich für den Inhalt: Dr. J. Tischer; Stand: Juni 2015